作者: Katrin Tertsch , Isabell Schoettle , Annika Hagendorf , Werner Müller , Gerrit Hauck
DOI:
关键词:
摘要: The invention relates to a liquid composition comprising GLP-1 agonist or/and pharmacologically tolerable salt thereof, an insulin and optionally at least one pharmaceutically acceptable adjuvant, the being characterised in that it contains methionine, as add-on therapy with metformin.